Degebassa Dida | Addis Ababa University (original) (raw)
I am communication engineer and I have rich experience telecommunications sector.Degebassa Dida
less
Related Authors
Graduate Center of the City University of New York
UERJ - Universidade do Estado do Rio de Janeiro / Rio de Janeiro State University
Uploads
Papers by Degebassa Dida
Journal of digestive diseases, Jan 17, 2016
To investigate the safety and efficacy of transarterial lipiodolized chemoembolization (TACE) wit... more To investigate the safety and efficacy of transarterial lipiodolized chemoembolization (TACE) with Embospheres for the treatment of inoperable hepatocellular carcinoma (HCC). From May 2010 to March 2014, 110 inoperable HCC patients were divided into two groups in this retrospective study. The Embo-TACE group received lipiodol and a chemotherapeutic agent emulsion followed by Embospheres. The cTACE group received conventional TACE (lipiodol and chemotherapeutic agent emulsion) followed by gelatin-sponge pellets. Time to progression (TTP), overall survival (OS), overall response rate (ORR), and safety were compared. A multivariate analysis of the factors affecting survival was also conducted. The median TTP and OS in the Embo-TACE group were significantly longer than in the cTACE group (7.0 months, 95% CI: 4.285-9.715 vs. 5.4 months, 95% CI: 3.619-7.181, P = 0.035; 15 months, 95% CI: 12.374-17.626 months vs. 12 months 95% CI: 10.434-13.566 months, P = 0.032). Seven days after the firs...
Journal of digestive diseases, Jan 17, 2016
To investigate the safety and efficacy of transarterial lipiodolized chemoembolization (TACE) wit... more To investigate the safety and efficacy of transarterial lipiodolized chemoembolization (TACE) with Embospheres for the treatment of inoperable hepatocellular carcinoma (HCC). From May 2010 to March 2014, 110 inoperable HCC patients were divided into two groups in this retrospective study. The Embo-TACE group received lipiodol and a chemotherapeutic agent emulsion followed by Embospheres. The cTACE group received conventional TACE (lipiodol and chemotherapeutic agent emulsion) followed by gelatin-sponge pellets. Time to progression (TTP), overall survival (OS), overall response rate (ORR), and safety were compared. A multivariate analysis of the factors affecting survival was also conducted. The median TTP and OS in the Embo-TACE group were significantly longer than in the cTACE group (7.0 months, 95% CI: 4.285-9.715 vs. 5.4 months, 95% CI: 3.619-7.181, P = 0.035; 15 months, 95% CI: 12.374-17.626 months vs. 12 months 95% CI: 10.434-13.566 months, P = 0.032). Seven days after the firs...